Smart Glass Market Size & Share to Surpass USD 10.7 Billion 15-03-2023, 22:40

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

nCino Announces Joaquín de Valenzuela as Managing Director for EMEA 30-10-2024, 17:02